Identification of a Potential Tumor Differentiation Factor (tdf) Receptor from Steroid-responsive and Steroid-resistant Breast Cancer Cells
نویسندگان
چکیده
IDENTIFICATION OF A POTENTIAL TUMOR DIFFERENTIATION FACTOR (TDF) RECEPTOR FROM STEROID-RESPONSIVE AND STEROID-RESISTANT BREAST CANCER CELLS Izabela Sokolowska, Alisa G. Woods, Mary Ann Gawinowicz, Urmi Roy and Costel C. Darie From Department of Chemistry & Biomolecular Science, Biochemistry & Proteomics Group, Clarkson University, 8 Clarkson Avenue, Potsdam, NY, 13699-5810 and Protein Core Facility, Columbia University, College of Physicians & Surgeons, 160 Fort Washington Avenue, Room 415, New York, NY, 10032
منابع مشابه
Tumor and Stem Cell Biology Metastatic Progression with Resistance to Aromatase Inhibitors Is Driven by the Steroid Receptor Coactivator SRC-1
Aromatase inhibitors (AI) are a standard-of-care treatment for postmenopausal, estrogen receptor–positive breast cancers. Although tumor recurrence on AI therapy occurs, themechanisms underlying acquired resistance to AIs remain unknown. In this study, we examined a cohort of endocrine-treated breast cancer patients and used a cell line model of resistance to the AI letrozole. In patients treat...
متن کاملThe hormonal milieu in primary breast cancer: A correlation between steroid receptors and serum estradiol, progesterone and prolactin
Background: The female breast is subjected to a lifetime of hormonal controls, whose effect is evident at the time of menarche and during the menstrual cycle, pregnancy and lactation. Studies have reported multiple risk factors for breast cancer, some of which are a reflection of hormonally mediated events. The steroid receptors are also served as prognostic factors for evaluating status of mal...
متن کاملMetastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1.
Aromatase inhibitors (AI) are a standard-of-care treatment for postmenopausal, estrogen receptor-positive breast cancers. Although tumor recurrence on AI therapy occurs, the mechanisms underlying acquired resistance to AIs remain unknown. In this study, we examined a cohort of endocrine-treated breast cancer patients and used a cell line model of resistance to the AI letrozole. In patients trea...
متن کاملGlobal characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.
The development of breast cancer resistance to endocrine therapy results from an increase in cellular plasticity that permits the emergence of a hormone-independent tumor. The steroid coactivator protein SRC-1, through interactions with developmental proteins and other nonsteroidal transcription factors, drives this tumor adaptability. In this discovery study, we identified ADAM22, a non-protea...
متن کاملCorrelation of Hormone Receptor Expression with Histologic Parameters in Benign and Malignant Breast Tumors
Background and Objective: Breast cancer is the commonest cancer of Indian women. Estrogen and Progesterone expression is seen in benign breast lesions and in breast carcinoma associated with good prognostic parameters and it correlates well with response to hormone therapy. Although a lot of studies have been conducted in the past on hormone receptor expression in breast cancer and few have cor...
متن کامل